US Stock MarketDetailed Quotes

ENFN Enfusion

Watchlist
  • 10.070
  • +0.220+2.23%
Close Jan 3 16:00 ET
  • 10.070
  • 0.0000.00%
Post 16:01 ET
950.33MMarket Cap251.75P/E (TTM)

Enfusion Key Stats

Enfusion Q3 2024 Earnings Date

Currency:USDNov 4, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
52.17M
51.17M
-1.00M
Miss Est.
+17.61%
+15.35%
-1.92%
EPS
0.03
0.02
-0.01
Miss Est.
+56.50%
0.00%
-36.10%
Strong Buy

Dec 31, 2024

Enfusion Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 56.395M--
--2024/Q4-- / 54.661M--
Nov 4, 20242024/Q351.166M / 52.167M--
Aug 6, 20242024/Q249.455M / 49.975M--
May 9, 20242024/Q148.052M / 47.616M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 56.395M--
--2024/Q4-- / 54.661M--
Nov 4, 20242024/Q351.166M / 52.167M--
Aug 6, 20242024/Q249.455M / 49.975M--
May 9, 20242024/Q148.052M / 47.616M--

Unlock Free Earnings Estimates

Enfusion Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data